Tag Archives: cancer

“Blood test finds 50 types of cancer” – we’ve been down this path before

Shoddy, incomplete, fawning news coverage of screening tests is one of the most clearly established problems in health news coverage – something HealthNewsReview.org has revealed countless times over the past 15 years. A public relations news release 22 days ago – from “a healthcare company whose mission is to detect cancer early” – touted study… Read More »

My vague symptoms and bouts of tiredness turned out to be incurable lung cancer

Oonagh McArdle had always been a healthy, fit, non-smoker so when she began experiencing “strange” symptoms in 2019, she was only mildly concerned, but decided to visit her doctor just in case. Several months and tests later, she received the biggest shock of her life when it was discovered that the strange feeling in her… Read More »

Sugary drinks and increased colon cancer risk linked in study involving nurses

Young adults who drink sugary beverages may be at an increased risk of developing colon cancer, researchers claim. The study, which involved 116,500 female nurses from 1991 to 2015, found that compared with women who drank less than one 8-ounce serving per week of sugar-sweetened beverages, those who drank two or more per day had… Read More »

Gap in Breast Cancer Survival for Black, White Patients Shrinks, But Not by Enough

By Amy Norton HealthDay Reporter FRIDAY, July 2, 2021 — Racial disparities in breast cancer survival have narrowed in recent years, but Black women with the disease still have double the death rate of white women. That’s according to a study that tracked breast cancer trends in Florida between 1990 and 2015. Overall, deaths from… Read More »

Astellas’ Xtandi nabs leg up over Johnson & Johnson’s Erleada with NICE prostate cancer win in UK

During the pandemic, Astellas’ oral prostate cancer drug Xtandi scored an interim nod in England as a “COVID friendly” way to treat men at home instead of in hospitals. With the pandemic easing there, cost watchdogs are backing the drug’s use for thousands of patients, offering the company an edge over its rival Johnson & Johnson. The National… Read More »